Literature DB >> 16698128

Plasma beta amyloid and impaired CO2-induced cerebral vasomotor reactivity.

Ewoud J van Dijk1, Niels D Prins, Albert Hofman, Cornelia M van Duijn, Peter J Koudstaal, Monique M B Breteler.   

Abstract

Amyloid beta (Abeta) may disturb cerebral autoregulation by damaging the wall of small cerebral blood vessels and by direct negative vasoactive properties. We assessed whether previous and concurrent plasma Abeta(1-40) and Abeta(1-42) levels were associated with an impaired CO2-induced cerebral vasomotor response. In the longitudinal population-based Rotterdam Study we measured plasma Abeta levels and cerebral vasomotor reactivity to hypercapnia with transcranial Doppler ultrasonography (TCD) in 441 people, aged 60-90 years. We performed age and sex adjusted logistic regression analysis. Plasma Abeta levels assessed on average 6.5-year before TCD were linearly associated with an impaired CO2-induced cerebral vasomotor response (odds ratio 1.48 (95%CI 1.19;1.84) per standard deviation increase in Abeta(1-40), and 1.36 (95%CI 1.09;1.70) per standard deviation increase in Abeta(1-42)). Such an association was not present for Abeta assessed concurrently with the TCD measurement. Persons whose plasma Abeta(1-40) levels had decreased in the 6.5-year period preceding TCD measurements were more likely to have an impaired CO2-induced vasomotor reactivity. Overall our observations are most compatible with plasma Abeta levels representing vascular Abeta deposits years later resulting in impaired CO2-induced vasomotor reactivity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16698128     DOI: 10.1016/j.neurobiolaging.2006.03.011

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  6 in total

1.  Scavenger receptor CD36 is essential for the cerebrovascular oxidative stress and neurovascular dysfunction induced by amyloid-beta.

Authors:  Laibaik Park; Gang Wang; Ping Zhou; Joan Zhou; Rose Pitstick; Mary Lou Previti; Linda Younkin; Steven G Younkin; William E Van Nostrand; Sunghee Cho; Josef Anrather; George A Carlson; Costantino Iadecola
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-07       Impact factor: 11.205

Review 2.  Biochemical markers of aging for longitudinal studies in humans.

Authors:  Peter M Engelfriet; Eugène H J M Jansen; H Susan J Picavet; Martijn E T Dollé
Journal:  Epidemiol Rev       Date:  2013-02-04       Impact factor: 6.222

3.  Impaired visual evoked flow velocity response in cerebral amyloid angiopathy.

Authors:  E E Smith; M Vijayappa; F Lima; P Delgado; L Wendell; J Rosand; S M Greenberg
Journal:  Neurology       Date:  2008-10-28       Impact factor: 9.910

4.  Deficits in synaptic function occur at medial perforant path-dentate granule cell synapses prior to Schaffer collateral-CA1 pyramidal cell synapses in the novel TgF344-Alzheimer's Disease Rat Model.

Authors:  Lindsey A Smith; Lori L McMahon
Journal:  Neurobiol Dis       Date:  2017-12-01       Impact factor: 5.996

5.  Plasma Abeta, homocysteine, and cognition: the Vitamin Intervention for Stroke Prevention (VISP) trial.

Authors:  A Viswanathan; S Raj; S M Greenberg; M Stampfer; S Campbell; B T Hyman; M C Irizarry
Journal:  Neurology       Date:  2009-01-20       Impact factor: 9.910

6.  Early neurovascular dysfunction in a transgenic rat model of Alzheimer's disease.

Authors:  Illsung L Joo; Aaron Y Lai; Paolo Bazzigaluppi; Margaret M Koletar; Adrienne Dorr; Mary E Brown; Lynsie A M Thomason; John G Sled; JoAnne McLaurin; Bojana Stefanovic
Journal:  Sci Rep       Date:  2017-04-12       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.